TARP peptide-pulsed autologous dendritic cell vaccine (NCI)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTARP peptide-pulsed autologous dendritic cell vaccine (NCI)

Drug Alias NameTARP肽脉冲的自体树突细胞疫苗-美国国立癌症研究所

ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Cancer Institute

China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A